Timasheva, Yanina,
Balkhiyarova, Zhanna,
Avzaletdinova, Diana,
Morugova, Tatyana,
Korytina, Gulnaz F.,
Nouwen, Arie,
Prokopenko, Inga,
Kochetova, Olga (2024) phenotypes remain unclear. We aimed to identify
genetic variants linked to eating behaviour and investigate
Ivanova, E.,
Gilyazova, I.,
Pavlov, V.,
Izmailov, A.,
Gimalova, G.,
Karunas, A.,
Prokopenko, I.,
Khusnutdinova, E. (2022) individuals without the disease. Individual
genetic risks were defined using the SNP-variant effects derived
Solovyev, A.V.,
Dzhemileva, L.U.,
Posukh, O.L.,
Barashkov, N.A.,
Bady-Khoo, M.S.,
Lobov, S.L.,
Popova, N.Y.,
Romanov, G.P.,
Sazonov, N.N.,
Bondar, A.A.,
Morozov, I.V.,
Tomsky, M.I.,
Fedorova, S.A.,
Khusnutdinova, E.K. (2017) sensory disorder. The
results of the molecular-based studies of HI are widely used
in various
genetic test
Johnson, N.,
Maguire, S.,
Morra, A.,
Kapoor, P.M.,
Tomczyk, K.,
Jones, M.E.,
Schoemaker, M.J.,
Gilham, C.,
Bolla, M.K.,
Wang, Q.,
Bermisheva, M. (2021) in the aetiology of breast cancer. The aim of this analysis was to identify
genetic variants that are associated
Shnayder, Natalia A.,
Ashhotov, Azamat V.,
Trefilova, Vera V.,
Novitsky, Maxim A.,
Medvedev, German V.,
Petrova, Marina M.,
Narodova, Ekaterina A.,
Kaskaeva, Daria S.,
Chumakova, Galina A.,
Garganeeva, Natalia P.,
Lareva, Natalia V.,
Al-Zamil, Mustafa,
Asadullin, Azat R.,
Nasyrova, Regina F. (2023) engineering);
genetic technologies (gene modifications, microRNA, and molecular inducers of IDD); technologies